Credit Agricole’s NanoViricides NNVC Stock Holding History

Credit Agricole’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-52,708	Closed	-$67M	–	1527
2017 Q1	$67M	Buy	+52,708	New	+$1.23M	0.2%	120

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

PTB

Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Credit Agricole's NNVC Position: Q2 2017 in Review

Credit Agricole sold out of NanoViricides (NNVC) in Q2 2017, closing a stake of 52,708 shares — an estimated $67M sold.

Credit Agricole first reported a position in NNVC in Q1 2017 and held it in 1 quarter. The position peaked at $67M in Q1 2017. 44 funds tracked by Wall St. Rank hold NNVC as of Q2 2017.

Credit Agricole reported no remaining NanoViricides position as of Q2 2017 after selling out during the quarter.
Credit Agricole sold 52,708 NanoViricides shares in Q2 2017, an estimated $67M.
Credit Agricole first reported a position in NanoViricides in Q1 2017 and held it in 1 quarter.
Credit Agricole's NanoViricides position peaked at $67M in Q1 2017.
44 funds tracked by Wall St. Rank held NanoViricides as of Q2 2017.

Based on Credit Agricole's 13F filing for Q2 2017, filed 14 Aug 2017.